Sfoglia per AUTORE
BENEDETTI F
Collezione AOU San Luigi di Orbassano

  

Items : 4

Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo. in Molecular cancer therapeutics / Mol Cancer Ther. 2021 Jun;20(6):1039-1051. doi: 10.1158/1535-7163.MCT-20-0521. Epub 2021 Mar 30.
2021
AOU San Luigi di Orbassano

Iuliano L; Drioli S; Pignochino Y; Cafiero CM; Minisini M; D'Este F; Picco R; Dalla E; Giordano G; Grignani G; Di Giorgio E; Benedetti F; Felluga F; Brancolini C;

2019
AOU Alessandria
AOU San Luigi di Orbassano

Mantoan B; Gueli A; Billio A; Angrilli F; Perrone T; Lanza F; Semenzato G; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Di Raimondo F; Stelitano C; Rota-Scalabrini D; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Bruna R; et alii...

2016
AOU San Luigi di Orbassano

Scagliotti G; Nishio M; Satouchi M; Valmadre G; Niho S; Galetta D; Cortinovis D; Benedetti F; Yoshihara E; Makris L; Inoue A; Kubota K;

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.
2011
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;